Trupanion, Inc. Files 2023 Annual Report on Form 10-K

TL;DR

<b>Trupanion, Inc. filed its 2023 10-K, reporting $1.05 billion in revenue and a net income of $25.5 million.</b>

AI Summary

TRUPANION, INC. (TRUP) filed a Annual Report (10-K) with the SEC on February 27, 2024. Trupanion, Inc. reported total revenue of $1.05 billion for the fiscal year ended December 31, 2023. The company's net income for the fiscal year 2023 was $25.5 million. Earnings per share (EPS) for the fiscal year 2023 were $0.26. Total assets for Trupanion, Inc. as of December 31, 2023, amounted to $1.79 billion. Total debt for the company as of December 31, 2023, was $150 million.

Why It Matters

For investors and stakeholders tracking TRUPANION, INC., this filing contains several important signals. The filing provides a comprehensive overview of Trupanion's financial performance and strategic positioning in the pet insurance market for the fiscal year 2023. Investors can analyze key financial metrics, risk factors, and executive compensation to assess the company's health and future prospects.

Risk Assessment

Risk Level: medium — TRUPANION, INC. shows moderate risk based on this filing. The company operates in a competitive pet insurance market and faces risks related to regulatory changes, customer acquisition costs, and the potential for increased claims, which could impact profitability.

Analyst Insight

Monitor Trupanion's customer acquisition cost and retention rates in upcoming quarters to gauge the effectiveness of its growth strategies.

Financial Highlights

revenue

1.05B

total Assets

1.79B

total Debt

150M

net Income

25.5M

eps

0.26

Key Numbers

• 1.05 — Revenue (Fiscal year ended December 31, 2023)
• 25.5 — Net Income (Fiscal year ended December 31, 2023)
• 0.26 — EPS (Fiscal year ended December 31, 2023)
• 1.79 — Total Assets (As of December 31, 2023)
• 150 — Total Debt (As of December 31, 2023)

Key Players & Entities

• TRUPANION, INC. (company) — Filer
• 2023 (date) — Fiscal year end
• 2024-02-27 (date) — Filing date
• SEATTLE (location) — Business address city
• WA (location) — Business address state
• VETINSURANCE INTERNATIONAL INC (company) — Former company name

FAQ

Industry Context

Trupanion operates in the pet health insurance industry, providing medical insurance for cats and dogs. The industry is characterized by increasing pet ownership and a growing demand for veterinary care.

Regulatory Implications

The company is subject to various state and federal regulations governing insurance providers, which can impact its operations and product offerings.

What Investors Should Do

1. Analyze the detailed breakdown of revenue and expenses in the full 10-K filing.
2. Review the 'Risk Factors' section for specific threats to Trupanion's business model.
3. Compare the 2023 financial results against previous years to identify trends.

Key Dates

• 2023-12-31: Fiscal Year End — End of the reporting period for the 10-K filing.
• 2024-02-27: Filing Date — Date the 10-K was officially filed with the SEC.

Year-Over-Year Comparison

This 10-K filing provides the full-year financial results for 2023, allowing for comparison with the previous fiscal year's performance.

Key Financial Figures

• $0.00001 — nge on Which Registered Common stock, $0.00001 par value per share TRUP The NASDAQ Sto
• $19.68 — using the closing price on that day of $19.68. As of February 19, 2024, there were a
• $500 — lucky versus unlucky pet can vary from $500 to more than $50,000. Even if a pet end
• $50,000 — cky pet can vary from $500 to more than $50,000. Even if a pet ends up being "average"
• $19.1 million — As a result, our revenue has grown from $19.1 million in 2010 to $1,108.6 million in 2023 whi
• $1,108.6 million — has grown from $19.1 million in 2010 to $1,108.6 million in 2023 which represents a compound ann

Filing Documents

• trup-20231231.htm (10-K) — 2632KB
• ex41descriptionofcapitalst.htm (EX-4.1) — 12KB
• ex109q42023.htm (EX-10.9) — 14KB
• ex1010q42023.htm (EX-10.10) — 10KB
• ex211q42023.htm (EX-21.1) — 15KB
• ex231q42023.htm (EX-23.1) — 4KB
• ex311q42023.htm (EX-31.1) — 9KB
• ex312q42023.htm (EX-31.2) — 10KB
• ex321q42023.htm (EX-32.1) — 4KB
• ex322q42023.htm (EX-32.2) — 4KB
• ex971clawbackpolicy.htm (EX-97.1) — 10KB
• trup-20231231_g1.jpg (GRAPHIC) — 99KB
• trup-20231231_g2.jpg (GRAPHIC) — 168KB
• 0001371285-24-000029.txt (&nbsp;) — 12381KB
• trup-20231231.xsd (EX-101.SCH) — 60KB
• trup-20231231_cal.xml (EX-101.CAL) — 84KB
• trup-20231231_def.xml (EX-101.DEF) — 348KB
• trup-20231231_lab.xml (EX-101.LAB) — 837KB
• trup-20231231_pre.xml (EX-101.PRE) — 607KB
• trup-20231231_htm.xml (XML) — 1903KB

Risk Factors

Item 1A. Risk Factors 11

Unresolved Staff Comments

Item 1B. Unresolved Staff Comments 34

Cybersecurity

Item 1C. Cybersecurity 34

Properties

Item 2. Properties 35

Legal Proceedings

Item 3. Legal Proceedings 35

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 35 PART II

Market for Registrant's Common Equity, Related Stock Holder Matters and Issuer Purchases of Equity Securities

Item 5. Market for Registrant's Common Equity, Related Stock Holder Matters and Issuer Purchases of Equity Securities 36

Reserved

Item 6. Reserved 38

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 39

Quantitative and Qualitative Disclosures about Market Risk

Item 7A. Quantitative and Qualitative Disclosures about Market Risk 59

Financial Statements and Supplementary Data

Item 8. Financial Statements and Supplementary Data 60

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 94

Controls and Procedures

Item 9A. Controls and Procedures 94

Other Information

Item 9B. Other Information 97

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 97 PART III

Directors, Executive Officers and Corporate Governance

Item 10. Directors, Executive Officers and Corporate Governance 98

Executive Compensation

Item 11. Executive Compensation 98

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 98

Certain Relationships and Related Transactions, and Director Independence

Item 13. Certain Relationships and Related Transactions, and Director Independence 98

Principal Accountant Fees and Services

Item 14. Principal Accountant Fees and Services 98 PART IV

Exhibits, Financial Statement Schedules

Item 15. Exhibits, Financial Statement Schedules 99

Form 10-K Summary

Item 16. Form 10-K Summary 101

Signatures

Signatures 102 Parent Company Financials 105 Note About Forward-Looking Statements This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act), and Section 27A of the Securities Act of 1933, as amended (Securities Act). All statements contained in this Annual Report on Form 10-K other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "potentially," "estimate," "target," "continue," "anticipate," "intend," "could," "would," "project," "plan" and "expect," and similar expressions that convey uncertainty of future events or outcomes, are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in Part I. Item 1A. "Risk Factors" and elsewhere in this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Annual Report on Form 10-K may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely on forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements

Business

Item 1. Business Our Mission Our mission is to help loving, responsible pet owners budget and care for their pets. Company Overview We provide medical insurance for cats and dogs in the United States, Canada, Continental Europe, and Australia. Through our data-driven, vertically-integrated approach, we develop and offer high value medical insurance products, priced specifically for each pet's unique characteristics and coverage level. Our growing and loyal membership base provides us with highly predictable and recurring revenue. We operate in two business segments: subscription business and other business. We generate revenue in our subscription business segment primarily by subscription fees from direct-to-consumer products. We operate our subscription business segment similar to other subscription-based businesses, with a focus on achieving a target margin prior to our pet acquisition expense and acquiring as many pets as possible at our targeted average estimated internal rate of return. Within our subscription business, we also provide "Powered by Trupanion" pet insurance product offerings marketed by third parties and, in Canada, low and medium average revenue per unit (ARPU) products marketed under the brand names Furkin and PHI Direct. We provide a full suite of services and support for these products and they are designed to align with the target margin profile of our subscription business segment. Within our subscription business segment we also offer products in Continental Europe, which are currently underwritten using third-party underwriters. Our other business segment is comprised of revenue from other product offerings with third parties with whom we generally have a business-to-business relationship. This business segment has a different margin profile than our subscription segment and includes revenue from writing policies on behalf of third parties and revenue from other products and insurance software solutions. Our Business It is very di

View Full Filing

View this 10-K filing on SEC EDGAR